IL22 and cancer: The results inspired the authors to investigate the mechanisms undergirding these findings, and they discovered that IL-22-mediated tumour stemness was associated with the methylation of H3K79 in three core cancer stemness genes: NANOG, SOX2 and Pou5F1.